Related Experiment Videos

The pathophysiology of the onset of morning cardiovascular events

M T Johnstone1, M Mittleman, G Tofler

  • 1Institute for the Prevention of Cardiovascular Disease, Deaconess Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.

Insights

Daily activities and stress can trigger heart attacks (myocardial infarction) and sudden cardiac death, particularly in the morning. Medications like beta-blockers and aspirin may reduce these risks.

Area of Science:

  • Cardiovascular Medicine
  • Circadian Biology
  • Preventive Cardiology

Background:

  • Myocardial infarction (MI) and sudden death are often triggered by daily activities, not random events.
  • A morning peak in onset for MI, sudden cardiac death, and stroke suggests a circadian influence.
  • Plaque rupture and subsequent thrombus formation are key mechanisms in acute MI.

Purpose of the Study:

  • To investigate the role of daily activities and physiological factors in triggering acute cardiovascular events.
  • To explore the hypothesis that stress-induced plaque rupture and thrombosis contribute to MI.
  • To understand the circadian variation in cardiovascular disease onset for improved prevention strategies.

Main Methods:

  • Review of evidence on triggers for myocardial infarction and sudden death.
  • Analysis of the temporal relationship between daily activities, stress, and cardiovascular events.
  • Examination of the effects of beta-blockers and aspirin on the morning peak of MI onset.

Main Results:

  • Evidence suggests daily physical or mental stresses are significant triggers for MI and sudden death.
  • A distinct morning peak in the onset of MI, sudden cardiac death, and stroke is observed.
  • Beta-blockers and aspirin have demonstrated an ability to reduce the morning peak of acute MI onset.

Conclusions:

  • Circadian variations in cardiovascular disease onset highlight vulnerable periods for patients.
  • Understanding the mechanisms of plaque vulnerability and rupture is crucial for prevention.
  • Pharmacologic protection during vulnerable periods may improve outcomes for patients at risk of cardiovascular events.

Related Concept Videos